Gillian Rosemary Bullock,Marc De Gasparo,Sabina Maria Ganter
申请号：
US13158914
公开号：
US20120010258A1
申请日:
2011.06.13
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention relates to the use of an AT1 receptor antagonist or an AT2 receptor modulator, respectively, or a pharmaceutically acceptable salt thereof, for producing a pharmaceutical preparation for the treatment of conditions or diseases associated with the increase of AT1 receptors in the sub-epithelial area or increase of AT2 receptors in the epithelia.
